Medicare officials say costly Alzheimer’s drug to blame for large monthly jump in premium

Medicare officials say costly Alzheimer’s drug to blame for large monthly jump in premium

The increase guarantees that health care will gobble up a big chunk of the recently announced Social Security cost-of-living allowance, a boost that had worked out to $92 a month for the average retired worker, intended to help cover rising prices for gas and food that are pinching seniors.

Related:

Biogen probes death of Aduhelm user after brain swelling

Cost and controversy are limiting use of new Alzheimer’s drug

How an Unproven Alzheimer’s Drug Got Approved

Trump promises seniors $200 prescription drug gift certificates, but questions abound

Trump promises seniors $200 prescription drug gift certificates, but questions abound

The administration is getting its authority to ship the coupons from a Medicare demonstration program, a White House spokesman told STAT in a statement. The nearly $7 billion required to send the coupons, he said, would come from savings from Trump’s “most favored nations” drug pricing proposal. That regulation has also not yet been implemented — meaning the Trump administration is effectively pledging to spend $6.6 billion in savings that do not currently exist. The cards, he said, would be “actual discount cards for prescription drug copays.

Related:

Trump’s ‘most favored nation’ executive order on drug prices is a scam for seniors

Yet none of these reference pricing proposals show how they would directly reduce out-of-pocket costs for seniors at the pharmacy counter. For example, an Avalere study found that fewer than 1% of older adults in Medicare Part B would see a reduction in out-of-pocket costs as a result of the international pricing index model. In all likelihood, the prices of drugs in other countries will be more affected by the executive order than U.S. drug prices.